Neuburgh Advisers’s Cantel Medical Corporation CMD Stock Holding History

Neuburgh Advisers’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$311K	Sell	4,158 -1,210	-23%	-$103K	0.01%	578
2019 Q2	$433K	Buy	5,368 +352	+7%	+$24.8K	0.01%	501
2019 Q1	$336K	Buy	5,016 +858	+21%	+$65K	0.01%	546
2018 Q4	$310K	Hold	4,158	–	–	0.01%	528
2018 Q3	$383K	Buy	4,158 +902	+28%	+$85.9K	0.01%	546
2018 Q2	$320K	Hold	3,256	–	–	0.01%	530
2018 Q1	$363K	Hold	3,256	–	–	0.01%	493
2017 Q4	$335K	Buy	3,256 +572	+21%	+$57K	0.01%	523
2017 Q3	$253K	Buy	2,684 +374	+16%	+$29.5K	0.01%	547
2017 Q2	$180K	Buy	2,310 +968	+72%	+$72.7K	0.01%	604
2017 Q1	$108K	Sell	1,342 -44	-3%	-$3.5K	﹤0.01%	604
2016 Q4	$109K	Buy	+1,386	New	+$108K	﹤0.01%	574

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Neuburgh Advisers's CMD Position: Q3 2019 in Review

Neuburgh Advisers reduced its Cantel Medical Corporation (CMD) stake by 23% in Q3 2019, selling an estimated $103K and leaving 4,158 shares worth $311K. The position accounts for 0.01% of the portfolio, ranked #578.

Neuburgh Advisers first reported a position in CMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $433K in Q2 2019. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

Neuburgh Advisers held 4,158 shares of Cantel Medical Corporation worth $311K as of Q3 2019.
Neuburgh Advisers sold 1,210 Cantel Medical Corporation shares in Q3 2019, an estimated $103K.
Cantel Medical Corporation made up 0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #578 holding.
Neuburgh Advisers first reported a position in Cantel Medical Corporation in Q4 2016 and has held it in 12 quarters since.
Neuburgh Advisers's Cantel Medical Corporation position peaked at $433K in Q2 2019.
244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.